Jaume Pons Alx Oncology Holdings Inc (ALXO) insider trading activity

Jaume Pons is PRESIDENT & CSO of ALX ONCOLOGY HOLDINGS INC. Currently has a direct ownership of 591,510 shares of ALXO, which is worth approximately $845,859. The most recent transaction as insider was on Aug 14, 2024, when has been sold 1,937 shares (Common Stock) at a price of $2.58 per share, resulting in proceeds of $4,997. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 592K

0.33% 3M change

5.44% 12M change

Total Value Held $845,859

Jaume Pons Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 14 2024	SELL Open market or private sale	$4,997 $2.58 p/Share	1,937 Reduced 0.33%	591,510 Common Stock
Jul 11 2024	SELL Open market or private sale	$158,000 $7.9 p/Share	20,000 Reduced 3.26%	593,447 Common Stock
Jul 11 2024	BUY Exercise of conversion of derivative security	$19,800 $0.99 p/Share	20,000 Added 3.16%	613,447 Common Stock
Jul 01 2024	SELL Open market or private sale	$62,611 $5.82 p/Share	10,758 Reduced 1.78%	593,447 Common Stock
Jun 04 2024	SELL Open market or private sale	$168,600 $8.43 p/Share	20,000 Reduced 3.2%	604,205 Common Stock
Jun 04 2024	BUY Exercise of conversion of derivative security	$19,800 $0.99 p/Share	20,000 Added 3.1%	624,205 Common Stock
May 06 2024	SELL Open market or private sale	$318,400 $15.92 p/Share	20,000 Reduced 3.2%	604,205 Common Stock
May 06 2024	BUY Exercise of conversion of derivative security	$19,800 $0.99 p/Share	20,000 Added 3.1%	624,205 Common Stock
Apr 16 2024	SELL Open market or private sale	$710,000 $14.2 p/Share	50,000 Reduced 7.64%	604,205 Common Stock
Apr 16 2024	BUY Exercise of conversion of derivative security	$25,587 $0.99 p/Share	25,846 Added 3.8%	654,205 Common Stock
Apr 04 2024	SELL Open market or private sale	$223,000 $11.15 p/Share	20,000 Reduced 3.08%	628,359 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	30,000 Added 4.42%	648,359 Common Stock
Dec 29 2023	SELL Open market or private sale	$107,972 $15.04 p/Share	7,179 Reduced 1.15%	618,359 Common Stock
Jul 25 2023	BUY Grant, award, or other acquisition	-	89,000 Added 12.46%	625,538 Common Stock
Jun 30 2023	SELL Open market or private sale	$23,546 $7.34 p/Share	3,208 Reduced 0.59%	536,538 Common Stock
Dec 29 2022	SELL Open market or private sale	$35,778 $11.07 p/Share	3,232 Reduced 0.6%	539,746 Common Stock
Aug 05 2022	BUY Grant, award, or other acquisition	-	74,000 Added 11.99%	542,978 Common Stock
Feb 03 2022	BUY Exercise of conversion of derivative security	$35,023 $1.45 p/Share	24,154 Added 4.9%	468,978 Common Stock
Oct 19 2021	SELL Open market or private sale	$912,488 $54.64 p/Share	16,700 Reduced 3.62%	444,598 Common Stock
Oct 19 2021	SELL Open market or private sale	$912,488 $54.64 p/Share	16,700 Reduced 3.62%	444,598 Common Stock
Sep 20 2021	SELL Open market or private sale	$1,253,001 $75.03 p/Share	16,700 Reduced 3.49%	461,298 Common Stock
Aug 19 2021	SELL Open market or private sale	$1,052,935 $63.05 p/Share	16,700 Reduced 3.38%	477,998 Common Stock
Jul 19 2021	SELL Open market or private sale	$907,812 $54.36 p/Share	16,700 Reduced 3.27%	494,546 Common Stock
Jun 21 2021	SELL Open market or private sale	$976,783 $58.49 p/Share	16,700 Reduced 3.16%	511,246 Common Stock
May 19 2021	SELL Open market or private sale	$927,351 $55.53 p/Share	16,700 Reduced 3.07%	527,946 Common Stock

Jaume Pons

PRESIDENT & CSO

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALXO shares.

Notify only if

Value

Insider Trading

Get notified when an Alx Oncology Holdings Inc insider buys or sells ALXO shares.

Notify only if

Operation

Value

Type

News

Receive news related to ALX ONCOLOGY HOLDINGS INC

Track Activities on ALXO

Account